These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 32559765)
41. Tissue factor pathway inhibitor-2 (TFPI-2) recognizes the complement and kininogen binding protein gC1qR/p33 (gC1qR): implications for vascular inflammation. Peerschke EI; Petrovan RJ; Ghebrehiwet B; Ruf W Thromb Haemost; 2004 Oct; 92(4):811-9. PubMed ID: 15467913 [TBL] [Abstract][Full Text] [Related]
42. The antigenic binding site(s) of antibodies to factor XII associated with the antiphospholipid syndrome. Harris SL; Jones DW; Gallimore MJ; Nicholls PJ; Winter M J Thromb Haemost; 2005 May; 3(5):969-75. PubMed ID: 15869593 [TBL] [Abstract][Full Text] [Related]
43. Deletion mutagenesis of high molecular weight kininogen light chain. Identification of two anionic surface binding subdomains. Kunapuli SP; DeLa Cadena RA; Colman RW J Biol Chem; 1993 Feb; 268(4):2486-92. PubMed ID: 8428925 [TBL] [Abstract][Full Text] [Related]
44. Factor XII in coagulation, inflammation and beyond. Didiasova M; Wujak L; Schaefer L; Wygrecka M Cell Signal; 2018 Nov; 51():257-265. PubMed ID: 30118759 [TBL] [Abstract][Full Text] [Related]
45. Differential binding of factor XII and activated factor XII to soluble and immobilized fibronectin--localization of the Hep-1/Fib-1 binding site for activated factor XII. Schousboe I; Nystrøm BT; Hansen GH FEBS J; 2008 Oct; 275(20):5161-72. PubMed ID: 18793325 [TBL] [Abstract][Full Text] [Related]
46. The bradykinin-forming cascade: a historical perspective. Kaplan AP Chem Immunol Allergy; 2014; 100():205-13. PubMed ID: 24925400 [TBL] [Abstract][Full Text] [Related]
47. Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28-kDa fragment (amino acids 141-371). Page JD; Colman RW J Biol Chem; 1991 May; 266(13):8143-8. PubMed ID: 1708772 [TBL] [Abstract][Full Text] [Related]
49. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI. Mitropoulos KA Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760 [TBL] [Abstract][Full Text] [Related]
50. Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII. Joseph K; Tholanikunnel BG; Kaplan AP Proc Natl Acad Sci U S A; 2002 Jan; 99(2):896-900. PubMed ID: 11792853 [TBL] [Abstract][Full Text] [Related]
51. Factor XII does not initiate prekallikrein activation on endothelial cells. Røjkjaer R; Hasan AA; Motta G; Schousboe I; Schmaier AH Thromb Haemost; 1998 Jul; 80(1):74-81. PubMed ID: 9684789 [TBL] [Abstract][Full Text] [Related]
52. The multiligand-binding protein gC1qR, putative C1q receptor, is a mitochondrial protein. Dedio J; Jahnen-Dechent W; Bachmann M; Müller-Esterl W J Immunol; 1998 Apr; 160(7):3534-42. PubMed ID: 9531316 [TBL] [Abstract][Full Text] [Related]
53. Plasma contact activation by a fucosylated chondroitin sulfate and its structure-activity relationship study. Lin L; Xu L; Xiao C; Zhou L; Gao N; Wu M; Zhao J Glycobiology; 2018 Oct; 28(10):754-764. PubMed ID: 30016441 [TBL] [Abstract][Full Text] [Related]
54. Identification and characterization of plasma kallikrein-kinin system inhibitors from salivary glands of the blood-sucking insect Triatoma infestans. Isawa H; Orito Y; Jingushi N; Iwanaga S; Morita A; Chinzei Y; Yuda M FEBS J; 2007 Aug; 274(16):4271-86. PubMed ID: 17645545 [TBL] [Abstract][Full Text] [Related]
55. Model for surface-dependent factor XII activation: the roles of factor XII heavy chain domains. Shamanaev A; Ivanov I; Sun MF; Litvak M; Srivastava P; Mohammed BM; Shaban R; Maddur A; Verhamme IM; McCarty OJT; Law RHP; Gailani D Blood Adv; 2022 May; 6(10):3142-3154. PubMed ID: 35086137 [TBL] [Abstract][Full Text] [Related]